![Gaurav D. Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gaurav D. Shah
Chief Executive Officer at
ROCKET PHARMACEUTICALS, INC.
Net worth: 5 M $ as of 31/07/2026
Profile
Gaurav D.
Shah is currently Chief Executive Officer & Director at Rocket Pharmaceuticals, Inc. since 2018, President, Chief Executive Officer & Director at Rocket Pharmaceuticals Ltd. since 2015, and Chairman at Anjarium Biosciences AG since 2022.
Former roles include Medical Director at Eli Lilly & Co. from 2010 to 2011, Independent Director at Talaris Therapeutics, Inc., Head-Global Clinical Program at Novartis Corp.
from 2011 to 2015, and Assistant Professor-Oncology at The Trustees of Columbia University in The City of New York from 2009 to 2011.
Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Harvard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/08/2026 | 1,462,832 ( 1.34% ) | 5 M $ | 31/07/2026 |
Gaurav D. Shah active positions
| Companies | Position | Start |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Chief Executive Officer | 04/01/2018 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Chief Executive Officer | 01/09/2015 |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Chairman | 18/10/2022 |
Former positions of Gaurav D. Shah
| Companies | Position | End |
|---|---|---|
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/09/2015 |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2011 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2011 |
| TOUE BIOPAR | Director/Board Member | - |
Training of Gaurav D. Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Health Technology |
- Stock Market
- Insiders
- Gaurav D. Shah
